Clinical Trials Browser

Terminated × INDUSTRY × brigatinib × Clear all

NCT02706626 2023-01-26

Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors

Phase 2 Terminated

32 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung